Abstract
The primary objective of this study was to evaluate the safety and the effect of D-tagatose on the glycemic control of subjects with type 2 diabetes as determined by HbA1c levels at the end of 6 months of therapy using the subject's own baseline HbA1c level as a comparator. The determination of the minimal dose required to cause a statistically significant reduction in HbA1c was of particular interest. Eight weeks after screening, the qualifying subjects were randomized to receive one of three doses of D-tagatose: 2.5 g TID, 5.0 g TID or 7.5 g TID. Blood levels of HbA1c, fasting blood glucose concentrations, plasma lipids, changes in body weight, changes in body mass index, and change in insulin levels were checked at each study visit and at the end of the study. Treatment success, as measured by the reduction of HbA1c, was greatest for the 7.5 g D-tagatose dose group, although the difference between the treatments was not statistically significant. For fasting glucose, only the 7.5 g dosage group exhibited reductions from baseline at the 3- and 6-month time points. Mean body weights reduced in a dose-response fashion, with the 5.0 g and the 7.5 g D-tagatose doses providing the greatest reductions. D-tagatose at dosages of 2.5 g, 5.0 g, and 7.5 g TID for six months were well tolerated by this subject population. D-tagatose at 5.0 g TID was the minimal dose required to reduce HbA1c. D-tagatose at 7.5 g TID provided the greatest effect in most measured efficacy parameters.
Document Type
Article
Publication Date
10-2014
Funding Information
This research was supported in part by the Biospherics subsidiary of Spherix Incorporated. The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Repository Citation
Ensor, Mark; Williams, Jarrod; Smith, Rebecca; Banfield, Amy; and Lodder, Robert A., "Effects of Three Low-Doses of D-Tagatose on Glycemic Control Over Six Months in Subjects with Mild Type 2 Diabetes Mellitus Under Control with Diet and Exercise" (2014). Pharmaceutical Sciences Faculty Publications. 41.
https://uknowledge.uky.edu/ps_facpub/41
Notes/Citation Information
Published in Journal of Endocrinology, Diabetes & Obesity, v. 2, no. 4, article 1057, p. 1-7.
© 2014 Lodder et al.
Open Access stands for limitless use and reuse at the point of access through internet. JSciMed Central Open Access Journals deposit all its content under Creative Common Attribution License and it allows copyrights to disseminate the work.